Find therapies in clinical trials near you – page 814

Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

Study on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia

Study on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia

Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia

Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia

Study on Colchicine for Patients with Acute Heart Failure

Study on Colchicine for Patients with Acute Heart Failure

Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing Multiple Sclerosis Starting Anti-CD20 Therapy

Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing Multiple Sclerosis Starting Anti-CD20 Therapy

Study on the Safety and Immune Response of GSK's Herpes Zoster Vaccine in Immunocompromised Children Aged 1-17 with Kidney Transplants

Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Study on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer

Study on Montelukast for COVID-19 Patients at Higher Risk in Primary Care

Study on Montelukast for COVID-19 Patients at Higher Risk in Primary Care

Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia

Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination